October 2018: Quanta Wins Industrial Product Design of the Year at the Plastics Industry Awards 2018

Quanta Dialysis Technologies, today announces that the Company has won the "Industrial Product Design of the Year" award at the Plastics Industry Awards 2018. The design of the SC+ haemodialysis system focuses on providing an intuitive user experience, centring on a large, interactive graphical touchscreen that guides users through a treatment via logical steps. This intuitive, tablet-style approach, combined with ergonomic industrial design, is intended to provide patients with a simple yet powerful platform for managing their treatments around their lives. Furthermore, every detail of the user experience and product design is streamlined to provide maximum safety and ease of use. The small footprint and modern design of the SC+ machine blends unobtrusively into different environments, expanding the range of treatment options available to patients.

Click Here To Read The Full Press Release


August 2018: Quanta To Exhibit At The 11th UK Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 11th UK Annual Dialysis Conference, taking place from Thursday 20th to Friday 21st September, at the Lowry Hotel in Manchester, UK. The UK Annual Dialysis Conference theme for 2018 is 'Advancing Dialysis: Now and for the Future' and will focus on clinical challenges, innovative solutions and future advances in dialysis care. Quanta will exhibit the new look of its personal haemodialysis system, SC+, which it plans to launch in 2019. SC+ is designed to give patients flexibility and to empower them to take control of their dialysis, enabling them to fit treatment around everyday life.

Click Here To Read The Full Press Release


May 2018: Quanta To Exhibit At The 55th Annual ERA-EDTA Congress

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 55th Annual European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Thursday 24th to Sunday 27th May, at the Bella Center in Copenhagen, Denmark at booth number 4.151. Quanta will be showcasing its new look, state-of-the-art personal haemodialysis system, SC+, designed to offer patients flexibility enabling them to fit treatment around everyday life.

Click Here To Read The Full Press Release


April 2018: Quanta Successfully Completes Pilot Treatments in France

Quanta Dialysis Technologies, today announces that the Company has successfully completed a clinical pilot to treat patients in France. Building off its successful UK pilot, this is the first time Quanta's personal haemodialysis system, SC+ has been used outside the UK. The treatments took place over a two-week period with five patients in Hôpital Necker, Paris. The treatments were led by French nurses who were trained by Quanta. These initial treatments in France were in addition to the ongoing pilot study in the UK, which has so far resulted in more than 1,400 successful patient treatments.

Click Here To Read The Full Press Release


March 2018: Quanta To Present At The 38th Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be presenting at the 38th Annual Dialysis Conference (ADC), which runs from 3 to 6 March 2018 at the Marriott Orlando World Center in Florida, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's unique small, simple and powerful haemodialysis system, SC+, in the 'Home HD Machines' session chaired by Robert Lockridge, MD, on Sunday 4 March at 2:15pm. The session will include an update on the results of the SC+ Pilot Study, which includes extensive, successful, patient treatments at four NHS Trusts across the UK.

Click Here To Read The Full Press Release


September 2017: Quanta To Unveil SC+ Dialysis System at the 10th UK Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company is unveiling its SC+ personal haemodialysis system for market launch next year. Based on clinical experience obtained during Quanta's extensive pilot studies, which included over 1,100 successful patient treatments at four NHS Trusts across the UK, the Company has optimised SC+ for commercial launch. In addition to the small, simple-to-use and powerful features that already set SC+ apart from traditional dialysis machines, Quanta is introducing state-of-the-art technology enhancements that include a new user interface featuring a high resolution screen and improved touch functionality, improvements for usability and capabilities to integrate with digital health solutions.

Click Here To Read The Full Press Release


September 2017: Quanta To Exhibit at the 10th UK Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 10th UK Annual Dialysis Conference, taking place from Thursday 28th to Friday 29th September 2017, at the Lowry Hotel in Manchester, UK. The UK Annual Dialysis Conference theme for 2017 is 'Dialysis fit for the 21st century', which focuses on the challenges, improvements and outcomes faced by dialysis patients and clinicians in the UK. Patients, clinicians and researchers will explore and discuss topics of clinical interest, including effective integrated home dialysis models, clinical challenges in dialysis practice and quality improvement.

Click Here To Read The Full Press Release


September 2017: Quanta To Attend The German Society of Nephrology 9th Annual Congress 2017

Quanta Dialysis Technologies, today announces that the Company will be attending the German Society of Nephrology 9th Annual Congress 2017 (DGFN 2017) taking place from Thursday 14th to Sunday 17th September 2017, at the Congress Center Rosengarten in Mannheim, Germany.

Click Here To Read The Full Press Release


May 2017: Quanta To Exhibit At The 54th ERA-EDTA Congress

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the 54th European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress which runs from Saturday 3rd June to Tuesday 6th June at the IFEMA Conference Centre in Madrid, Spain at booth number 3.135. Quanta will be showcasing SC+, its easy-to-use, compact, haemodialysis system, offering high performance comparable to conventional devices and compatibility with traditional treatment regimens typically used in-centre. SC+ has been designed to provide flexibility and convenience to dialysis patients empowering them to regain control of their lives.

Click Here To Read The Full Press Release


May 2017: Quanta Dialysis Technologies Prepares To Launch SC+ Haemodialysis Machine

Quanta Dialysis Technologies is very excited to become part of the global kidney community as it approaches the 2018 commercial launch of its new haemodialysis system -the SC+. Over 64,000 people in the UK are currently being treated for end-stage renal disease and more than 24,000 undergo dialysis treatment to keep them alive. Quanta recognises that what most dialysis patients want is to be able to focus on their families, their work and their lives. Managing dialysis treatment can make that very challenging so there was clearly a need for a machine that is compact and easy to use, enabling greater flexibility and patient independence.

Click Here To Read The Full Article


May 2017: Tales From Dialysis Nights (Six Thousand Five Hundred and Counting)

As I write this I am sitting in the desert outside Dubai, about to start a busy day of fun, jumping out of aeroplanes and horse riding in the sand dunes. The only reason I am here now, pursuing life with a passion and living very happily and healthily is because of home dialysis. 20 year's ago my life was turned upside down by an aggressive onset of FSGS. I spent 18 months in Guy's Hospital undergoing treatment including steroids and chemotherapy plus an array of horrible complications. At 14 years old I had my kidneys removed and immediately opted to dialyse myself at home on overnight APD.

Click Here To Read The Full Article


April 2017: Quanta To Exhibit at the BRS Conference 2017

Quanta Dialysis Technologies, today announces that the Company will be exhibiting at the British Renal Society Conference 2017, which runs from 26 to 28 April 2017, at the David Ross Sports Village, Nottingham University, UK. At the conference, Quanta will present a poster that will report on the results of the first 660 treatments completed using SC+ in the UK at Nottingham University Hospitals', Guys and St. Thomas' Hospital and Queen Elizabeth Hospital, Birmingham.

Click Here To Read The Full Press Release


March 2017: Quanta To Present At The 37th Annual Dialysis Conference

Quanta Dialysis Technologies, today announces that the Company will be presenting at the 37th Annual Dialysis Conference, which runs from 11 to 14 March 2017, at the Long Beach Convention and Entertainment Center in California, USA. John E. Milad, Chief Executive Officer will provide an update on Quanta's, easy-to-use, compact haemodialysis system, SC+, in the "Home Haemodialysis Machines: Providing Optimal Haemodialysis with Minimal Burdens" session chaired by Robert Lockridge, MD, on Sunday 12 March. John will also report on usability testing results for SC+ as part of the "Slide Forum VI: Dialysis Systems" session on Monday, 13 March.

Click Here To Read The Full Press Release


February 2017: Next Generation Solutions In Renal Care Without Compromising On Performance

The NIHR has supported Quanta Dialysis Technologies in the development of SC+, a high performance, compact, easy-to-use haemodialysis system designed to improve the lives of patients and carers both in the clinic and the home.

Click Here To Read The Full Article


February 2017: Quanta Appoints World Leading Nephrologist To Medical Advisory Board

Quanta Dialysis Technologies, today announces it has appointed Dr Sandip Mitra to its Medical Advisory Board. Sandip is a practising Senior Consultant Nephrologist at Manchester Royal Infirmary where he leads one of the largest home haemodialysis programmes in Europe. He is a Principal Investigator on multicentre trials and is a recognised international advisor to global industry leaders in dialysis. Over the past 12 years he has held a number of research and clinical positions, including Renal Speciality Research Lead for the Clinical Research Network NIHR; Chair of Clinical Research Study Group for the UK Kidney Research Consortium NIHR; Renal Innovation Lead at MAHSC & Manchester Integrating Medicine & Innovative Technology (MIMIT); Clinical Chair, Renal Technology at NIHR Devices for Dignity; Senior Lecturer at the University of Manchester; and Clinical Governance Lead for the Hospital, Home and Minimal Care HD.

Click Here To Read The Full Press Release


September 2016: Quanta To Exhibit At The 9th Annual Conference On Home Dialysis

Quanta Dialysis Technologies Ltd, a medical device company providing innovative haemodialysis solutions for the clinic and the home, announces that the Company will be exhibiting at the 9th Annual Conference on Home Dialysis, today, Thursday 29th September until tomorrow, Friday 30th September, 2016, at the Lowry Hotel in Manchester, UK.

Click here to read the full press release


September 2016: Quanta To Present Interim Analysis Of First 255 Treatments Using SC+ At The 10th International Congress Of The ISHD

Quanta Dialysis Technologies Ltd, a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces that it will present a poster at a moderated session on Friday 23rd September at 11:30am-12:30pm at the 10th International Congress of the International Society of Haemodialysis (ISHD). The Congress will be held from Thursday 22nd to Saturday 24th September, 2016, at the Palais des congrès de Marrakech, Marrakech.

Click here to read the full press release


July 2016: Quanta Fluid Solutions Changes Name To Quanta Dialysis Technologies

Quanta Fluid Solutions Ltd, a medical device company providing innovative haemodialysis solutions for the clinic and the home, has today changed its name and will no longer be known as Quanta Fluid Solutions Ltd, effective immediately. The new name has been registered at Companies House. Quanta's new name better reflects the Company's current focus as an innovative medical technology Company rather than emphasising its roots in the fluidics industry.

Click here to read the full press release


June 2016: Quanta To Exhibit At UK Kidney Week 2016

Quanta Fluid Solutions, a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces that it will be exhibiting at UK Kidney Week 2016 from Tuesday 7th June to Friday 10th June at the International Conference Centre, Birmingham, B1 2EA, at booth number D36. In addition, quanta will present an abstract at the congress that will report on data from the Company's initial pilot studies in the United Kingdom using SC+ at the Nottingham University Hospitals NHS Trust; Guys and St Thomas' NHS Foundation Trust, London; and Queen Elizabeth Hospital, Birmingham. If you would like to arrange a meeting with Quanta at the congress please contact John E. Milad, CEO: enquiries@quantadt.com.

Click here to read the full press release


May 2016: Quanta To Exhibit At The 53rd ERA-EDTA Congress In Vienna, Austria

Quanta Fluid Solutions, a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces that the Company will be exhibiting at the 53rd European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress from Saturday 21st to Tuesday 24th May at the Austria Center Vienna, at booth number 3.71. In addition, quanta will present an abstract at the congress that will report on data from the Company's initial pilot studies in the United Kingdom using SC+ at the Nottingham University Hospitals NHS Trust; Guys and St Thomas' NHS Foundation Trust, London; and Queen Elizabeth Hospital, Birmingham. If you would like to arrange a meeting with Quanta at the congress please contact John E. Milad, CEO: enquiries@quantafs.com.

Click here to read the full press release


February 2016: Quanta To Present First Pilot Study Data At The 36th Annual Dialysis Conference

Quanta Fluid Solutions, a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces that the Company will be presenting at the 36th Annual Dialysis Conference which runs from 27th February to 1st March, at the Washington State Convention Center in Seattle, Washington, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's portable, cartridge-based haemodialysis system, SC+, in the "Home Hemodialysis Machines: How They Can Provide Optimal Hemodialysis" session (21A), chaired by Robert Lockridge, MD, on Sunday 28th February at 3.20pm.

Click here to read the full press release


February 2016: Mr Nadhim Zahawi, MP For Stratford on Avon, Visits Quanta

Quanta Fluid Solutions, a Midlands-based medical device company developing innovative haemodialysis solutions, announces that on 12 February 2016, Mr Nadhim Zahawi, MP for Stratford on Avon, visited the Company headquarters in Alcester. John E. Milad, CEO of Quanta, welcomed Mr Zahawi MP, who was provided a tour of Quanta's facilities, which included the research and development laboratory, and was given a demonstration of SC+, Quanta's novel compact, cartridge-based haemodialysis system.

Click here to read the full press release


November 2015: Quanta Appoints Dr Francesco Granata As Non-Executive Director

Quanta Fluid Solutions, a pioneer of advanced haemodialysis solutions, today announces the appointment of Dr Francesco Granata to the Company's Board as an independent Non-Executive Director, with immediate effect. Dr Francesco Granata has over 35 years of experience in the biopharmaceutical and medical products industries, with strong international commercial expertise. Francesco is currently Chairman of Circassia and also serves on the boards of private companies Italfarmaco SpA, Cell Therapy Ltd and Prismic Pharmaceuticals Inc.

Click here to read the full press release


October 2015: Quanta Treats First Patients With Advanced Haemodialysis System SC+

Quanta Fluid Solutions, a pioneer of advanced haemodialysis solutions, today announces it has successfully treated the first patients with SC+, its portable, cartridge-based haemodialysis system. The treatments were part of a pilot study designed to demonstrate safety, performance and usability of SC+ in a clinical setting with human dialysis patients. The results showed that all dialysis therapies were successfully and safely completed with no adverse events. Essential performance criteria, including urea clearance and ultrafiltration rate, were assessed and achieved their prescribed targets, clearly meeting the primary endpoints of the study.

Click here to read the full press release


October 2015: Quanta Appoints Dr Peter Kerr And Dr Elizabeth Lindley To Its Medical Advisory Board

Quanta Fluid Solutions, a pioneering developer of advanced haemodialysis systems, today announces the appointment of Dr Peter Kerr and Dr Elizabeth Lindley to the Company's Medical Advisory Board, with immediate effect. Dr Peter Kerr has a long and established career in nephrology and is a strong advocate of home-dialysis. He completed his undergraduate degree in medicine at Monash University, Melbourne, later returning to work there as a nephrologist and, since 2006, he has led the department as Professor and Director of Nephrology. Dr Elizabth Lindley is a Specialist Clinical Scientist working in the Department of Renal Medicine at the Leeds Teaching Hospitals NHS Trust. She is Co-Lead for the Renal Theme of the NIHR Devices for Dignity Healthcare Technology Co-operative and a facilitator for the UK Renal Technology course in Bradford.

Click here to read the full press release


September 2015: Quanta Appoints Giles Kerr As A Non-Executive Director

Quanta Fluid Solutions, a pioneering developer of advanced haemodialysis systems, today announces the appointment of Giles Kerr to the Company's Board as Non-Executive Director and as Audit Committee Chair, with immediate effect. Giles Kerr has a very successful commercial and financial track record with specific healthcare experience and a vast skill set covering all aspects of financial management. Giles is currently Chief Financial Officer at Oxford University and serves on the Board of BTG plc, where he is also Chairman of the Audit Committee and Senior Independent Director.

Click here to read the full press release


September 2015: Quanta To Exhibit At The 8th Annual Conference On Home Dialysis

Quanta Fluid Solutions, a pioneering developer of advanced haemodialysis systems, announces that the company will be exhibiting at the 8th Annual Conference on Home Dialysis, Booth C, from Thursday 24th to Friday 25th September, 2015 at the Lowry Hotel in Manchester, UK. The Annual Conference on Home Dialysis is focused on novel dialysis initiatives and the changing landscape of dialysis care in the UK. Clinicians, researchers and patients will explore and discuss topics of clinical interest, including new initiatives in paediatric practice and early results from clinical research trials.

Click here to read the full press release


August 2015: Quanta Receives £1.85 Million i4i Award To Develop An Advanced Haemodialysis System For Nocturnal Use

NHS NIHR Logo (National Institute for Health Research) Quanta Fluid Solutions, a pioneering developer of advanced haemodialysis systems, announces it has received an Invention for Innovation (i4i) award worth £1.85 million from the National Institute for Health Research (NIHR) - the research arm of the NHS - to develop a new product concept for nocturnal haemodialysis. Leveraging Quanta's knowledge and expertise established in the development of its CE marked, portable, cartridge based haemodialysis system, SC+, the award will be used to develop a new dialysis machine concept specifically targeted for nocturnal use. To do this, Quanta will develop a series of new technologies aimed at optimising the delivery of nocturnal dialysis.

Click here to read the full press release


May 2015: Quanta To Exhibit At The 52nd ERA-EDTA Congress

Quanta Fluid Solutions today announces that it will be exhibiting at the 52nd European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress from Thursday 28th to Sunday 31st May at the ExCel Exhibition Centre in London, UK, at booth number D145. ERA-EDTA is the world's largest congress on renal related illnesses and the technologies and therapeutics to treat them. Naturally, there is a strong focus on dialysis as a key treatment option for renal diseases making it the optimum place for Quanta to be present.

Click here to read the full press release


March 2015: INGENIA - Issue 62

The UK-produced SC+ portable haemodialysis machine will help drive a trend back to performing haemodialysis at home. It aims to relegate haemodialysis to a less demanding place in patients' lives using standard industry components, key of which is the disposable cartridge comprising some 90% of the hydraulic pipework required in haemodialysis.

Click here to read the full article


January 2015: Quanta To Present At The 35th Annual Dialysis Conference

Quanta Fluid Solutions today announces that the company will be presenting at the 35th Annual Dialysis Conference which runs from Saturday 31st January to Tuesday 3rd February at the Ernest N. Morial Convention Center in New Orleans, Louisiana, USA. Peter Hoyer, Chief Commercial Officer, will provide an update on Quanta's compact cartridge-based haemodialysis system SC+ in the "Demonstrations: Features and Results with Home Hemodialysis Machines" session.

Click here to read the full press release


January 2015: Professor John Agar's Blog: A New Kid(Ney) Prepares To Blast Off - The Quanta SC+

On the 6th January, 2015, Quanta Fluid Solutions, a company based in Warwickshire (UK), put out a press release to announce the success of their application for CE mark approval for their new portable home dialysis system; the Quanta SC+. So, what does a CE mark mean, and not mean?

Click here to read the full blog


January 2015: Quanta announces it has received CE mark for SC+

Quanta Fluid Solutions today announces that it has received CE mark for SC+, its portable, cartridge-based haemodialysis system. SC+ is designed to bring flexibility to dialysis patients and physicians by supporting all treatment regimens, from nurse-assisted care and patient self-care in-centre to home haemodialysis. Quanta is also pleased to announce that it has raised additional funds expanding its recent investment round to a total of £29 million.

Click here to read the full press release


November 2014: Daily Telegraph - Quanta Raises £27 Million to Launch Compact Dialysis Machine

IMI spin-out Quanta has raised £27m from investors to launch a new device that "could change the face of dialysis" as it gears up for a float next year. The Warwickshire-based group attracted funding from two new backers, one of which was lead investor ALIAD, the venture capital arm of French engineering giant Air Liquide. French investment house Seventure Partners also came in as a new investor.

Click here to read the full article


November 2014: Quanta Raises £27 Million to Prepare its Advanced Haemodialysis System SC+ for Launch

Quanta Fluid Solutions today announces that it has closed a fundraising of approximately £27 million. The funding round was led by ALIAD, the venture capital investment vehicle of Air Liquide SA, and included participation by new investor Seventure Partners, as well as existing investors Wellington Partners, Seroba Kernel, NBGI Ventures, b-to-v partners and IMI plc. Funds will be used to support the clinical introduction and commercial launch of SC+, Quanta's advanced haemodialysis system.

Click here to read the full press release


October 2014: Quanta wins Best Presentation at Entente Life Sciences Investment Forum 2014 in Brussels

Entente life sciences award Quanta Dialysis Technologies SC+ Portable selfcare home haemodialysis machineQuanta was awarded the best presentation by a panel including approximately 50 venture capitalists, corporate investors, business angels, and other industry experts. The award means Quanta has been selected to present at the 8th edition of the European Venture Summit (EVS) on the 8th and 9th of December in Düsseldorf.  

Click here to read the full press release


September 2014: Quanta Hopes to Reap Dialysis Riches

Quanta Fluid Solutions is close to CE marking its flagship SC+ portable haemodialysis device, and the first target the UK company is aiming for is the domestic market. Clinica caught up with CEO and former investor John Milad, who has been heading up Quanta since January.  

Click here to read the full press release


September 2014: Quanta Appoints Dr. Nicholas Hoenich to its Medical Advisory Board

Alcester, Warwickshire, UK, 1 September 2014: Quanta Fluid Solutions Ltd (“Quanta” or the “Company”), a pioneering developer of advanced haemodialysis systems, today announces the appointment of renal expert Dr. Nicholas Hoenich to its newly established Medical Advisory Board. Dr. Hoenich joins Prof. John Agar, Dr. Roger Greenwood, Dr. Clara Day and Mr. Tony Goovaerts, forming a strong panel of renal experts to support Quanta in the final stages of development of its high performance, portable, compact haemodialysis system, SC+, and subsequent clinical introduction.  

Click here to read the full press release


August 2014: Quanta to attend Goldman Sachs Medtech Conference

Alcester, Warwickshire, UK, 26 August 2014: Quanta Fluid Solutions Ltd (“Quanta” or the “Company”), a pioneering developer of advanced haemodialysis systems, today announces that John E. Milad, Chief Executive Officer, will be attending the Goldman Sachs Medtech Conference which will take place in London on 3-4 September, 2014. The event will provide an opportunity for Quanta to give investors an update on the company during one-to-one meetings.  

Click here to read the full press release


August 2014: Quanta Establishes Medical Advisory Board of World-Leading Renal Experts

Four internationally renowned renal care specialists to assist Quanta as it prepares for the clinical introduction of its advanced haemodialysis system  

Click here to read the full press release


August 2014: Quanta Appoints New Chief Financial Officer

Willem Baralet Chief Financial Officer Quanta Dialysis TechnologiesAlcester, Warwickshire, UK, 7th August 2014: Quanta Fluid Solutions Ltd (“Quanta” or the “Company”), a pioneering developer of advanced haemodialysis systems, today announces the appointment of Willem Baralt as Chief Financial Officer.  

Click here to read the full press release


June 2014: In VIVO Article - Quanta Fluid Solutions, Revitalizing Home Haemodialysis

A number of factors are coming together to drive a trend toward smaller, more flexible hemodialysis systems that are simple enough to be operated by patients in their own homes. Quanta Fluid Solutions, a young UK-based company, is poised to take advantage of this situation with the impending commercialization of its SelfCare+ system.

Click here to read the full article


April 2014: Quanta Chief Executive, John E. Milad, to speak at IN3 Medical Device 360° Dublin Conference.

The conference is being held on 9th April at the Shelbourne Hotel in Dublin, Ireland, starting at 9:50am IST.

Click here to read the full press release


March 2014: John E. Milad, Chief Executive Officer, will be speaking at the Economist’s Pharma Summit 2014 on Thursday 13th March at the Dorchester Hotel, London.

John will be speaking in the panel entitled: "The Funding Gap - Paying for the Future of R&D" alongside some of the industry’s most prominent leaders.  The panel starts at 3.35pm GMT.

Click here to read the full press release


Quanta to provide update and live demonstration of its compact, portable Haemodialysis System SelfCare+ at the 34th Annual Dialysis Conference

John E. Milad, Chief Executive Officer, and Peter Hoyer, Chief Commercial Officer, will be attending the 34th Annual Dialysis Conference from Saturday 8th February to Tuesday 11th February at the Georgia World Congress Centre in Atlanta, GA, USA.  

Click here to read the full press release


Quanta appoints new CEO, 8 January 2014

John low resJohn E. Milad has been appointed as the New Chief Executive Officer.

Click here to read the full press release


Quanta unveils SelfCare+ at Manchester (UK) Congress

Quanta 30-07-14Around 300 delegates at the 6th Manchester Conference on Home Dialysis in Manchester on October 3-4, 2013 attended the official presentation of SelfCare+ to the UK renal community.      

Click here to read the full press release


Quanta appoints new Director of Quality and Bio-safety

Director of Quality Quanta Dialysis TechnologiesQuanta has appointed Mr Jules Nancarrow as Director of Quality and Bio-safety.

Click here to read the full press release.


Quanta appoints Meinhard Schmidt as non-executive Director, 1 October 2012

Meinhard Schmidt Quanta Dialysis TechnologiesMeinhard Schmidt has been appointed as non-executive Director at Quanta Fluid Solutions, bolstering the board of the UK based medical technology company.  

Click here to read the full press release.


Quanta is awarded NHS Grant for the development of a Patient Centric self-care Haemodialysis machine

Quanta, in partnership with the NKF, Leeds University Hospital and Newcastle University, has been awarded the i4i "Invention for Innovation" grant which will enable the company to tailor the design of SelfCare+ to the needs of patients and of the NHS. The grant will help resource additional marketing, engineering and design specifically for patient usability and other patient centric aspects. David Oram, Quanta's Engineering Manager, says "Although SelfCare+ has always been intended to be used by patients; the i4i grant will enable us to go to the next level in patient usability design". Quanta will conduct extensive consultation via workshops and focus groups with patients and renal specialists from leading UK renal centres. The data gathered from these activities will enable Quanta to fine tune the design of SelfCare+ so that the entire dialysis process is as patient friendly as possible.


Director for Science Professor Clive Buckberry has been elected a Fellow of the Royal Academy of Engineering.

Professor Buckberry is distinguished for fundamental fibre optoelectronic speckle pattern interferometry developments and for creating and implementing laser photonic applications for automotive and other industries; exceptional for technical leadership of a medical engineering company spun out of IMI Vision; and outstanding for sustained, mutually fruitful university knowledge transfer.

To read more visit the Royal Academy of Engineering website


Peter Hoyer joins the Quanta Team as Sales and Marketing Director

Peter Hoyer Quanta Fluid SolsutionsWe are pleased to announce the appointment of Peter Hoyer to the position of Sales and Marketing Director. Peter will be responsible for the development and implementation of Quanta targeted sales and market development plans, building and extending partnerships with dialysis clinicians and overseeing all facets of Quanta's sales & marketing activities. "I am delighted to join the Quanta team and I can't wait to start helping improve the life of ESRD patients around the world. I am impressed by the unique product design and performance as well as the sophistication of the Quanta development & management team. SelfCare+ features a truly revolutionary treatment platform that is going to change the way the world looks at haemodialysis therapy.  

Click here to read the full press release.


View our current press releases

Quanta Dialysis Technologies, Self-Care+, SelfCareplus, SC+, Travel dialysis machine